envelop
virus
penetr
cell
target
follow
merg
membran
cell
fusion
process
catalyz
one
sever
viral
glycoprotein
incorpor
membran
viru
envelop
glycoprotein
envgp
evolv
order
combin
two
featur
first
acquir
domain
bind
specif
cellular
protein
name
receptor
second
develop
help
cellular
protein
function
fine
control
fusion
optim
replic
preserv
integr
cell
specif
genu
viru
follow
activ
envgp
either
bind
receptor
andor
sometim
acid
ph
endosom
mani
chang
conform
permit
ultim
action
specif
hydrophob
domain
fusion
peptid
destabil
cell
membran
lead
open
lipid
membran
comprehens
mechan
essenti
develop
medicin
therapeut
class
entri
inhibitor
like
enfuvirtid
fuzeon
human
immunodefici
viru
hiv
chapter
summar
differ
envelop
glycoprotein
structur
virus
develop
achiev
membran
fusion
entri
viru
describ
differ
entri
pathway
cellular
protein
virus
subvert
allow
infect
cell
receptor
use
final
illustr
precis
recent
discoveri
made
within
field
entri
process
focu
use
pseudoparticl
pseudoparticl
suitabl
highthroughput
screen
help
develop
natur
artifici
inhibitor
new
therapeut
class
entri
inhibitor
elsevi
inc
envelop
virus
core
incorpor
genet
materi
viru
surround
lipid
membran
acquir
cell
bud
genet
materi
enter
target
cell
follow
merg
membran
membran
cell
either
plasma
membran
membran
anoth
intern
compart
process
membran
merg
call
membran
fusion
preserv
integr
cell
membran
fusion
two
separ
lipid
bilay
nonaqu
environ
first
requir
come
close
contact
follow
intermedi
stage
character
merger
closest
contact
monolay
process
call
hemifus
third
fulli
complet
fusion
result
whole
bilay
merg
follow
open
pore
achiev
process
envelop
glycoprotein
envgp
evolv
order
combin
two
featur
one
hand
acquir
domain
bind
specif
cellular
protein
name
receptor
hand
develop
differ
manner
accord
genu
viru
function
fusion
allow
destabil
membran
open
pore
genet
materi
enter
cell
despit
three
differ
class
fusion
protein
describ
far
three
common
main
step
describ
achiev
preto
postconform
chang
first
one
envgp
activ
upon
receptor
bind
acidif
endosom
compart
expos
fusion
peptid
project
toward
top
glycoprotein
allow
initi
interact
target
membran
second
one
fold
back
ctermin
region
onto
trimer
ntermin
region
lead
format
postfus
protein
structur
final
third
step
also
requir
refold
membran
proxim
transmembran
region
order
obtain
fulllength
postfus
structur
membran
anchor
fusion
peptid
tm
domain
present
membran
viral
glycoproteininduc
fusion
must
control
allow
viru
leav
cell
prevent
aggreg
virus
releas
genet
materi
next
compart
permit
continu
infecti
cycl
regul
execut
princip
inactiv
mask
fusion
machineri
directli
disorgan
lipid
bilay
one
hand
envgp
synthes
precursor
requir
cleavag
cellular
proteas
like
furin
prepar
molecul
subsequ
necessari
chang
conform
fusion
process
hand
activ
conform
chang
induc
interact
receptor
andor
action
ph
proton
amino
acid
modifi
interact
envgp
structur
addit
proteas
enzym
necessari
achiev
complementari
prime
envgp
make
compet
fusion
cathepsin
b
l
two
type
fusion
mechan
occur
name
ph
independ
ph
depend
first
case
recognit
viru
receptor
directli
trigger
conform
chang
envgp
lead
direct
fusion
two
membran
viral
plasma
liber
viral
genet
materi
activ
envgp
neutral
ph
allow
fusion
vitro
vivo
envgpexpress
cell
receptorexpress
cell
fusion
lead
merg
cell
cytoplasm
gener
multinucl
cell
call
syncytia
second
case
phdepend
fusion
interact
envgp
receptor
lead
obligatori
endocytosi
virusreceptor
complex
acidif
endosom
trigger
conform
chang
envgp
phdepend
viru
fusion
reproduc
cell
cultur
vitro
liposomeviru
fusion
assay
tube
decreas
ph
occur
vivo
research
last
year
greatli
advanc
understand
cell
surfac
receptor
virus
provid
mani
surpris
insight
advanc
achiev
larg
identif
molecular
clone
cell
surfac
cytoplasm
protein
subvert
use
viral
receptor
cofactor
parallel
advanc
studi
viral
envgp
bind
receptor
anoth
key
area
new
insight
concern
physicalchem
process
viral
adsorpt
pull
viru
close
onto
cellular
membran
inde
adsorpt
sever
limit
step
infect
cultur
cell
initi
attach
often
involv
receptor
ultim
mediat
infect
andreadi
et
al
guibinga
et
al
pizzato
et
al
pizzato
et
al
ugolini
et
al
thu
need
distinguish
cell
surfac
molecul
heparan
sulfat
proteoglycan
dcsign
integrin
enhanc
infect
concentr
retrovirus
onto
cell
bounou
et
al
geijtenbeek
et
al
jinnoou
et
al
mondor
et
al
pohlmann
et
al
saphir
et
al
authent
receptor
induc
conform
chang
envgp
prerequisit
fusion
viral
cellular
membran
contrast
cell
surfac
compon
lectin
proteoglycan
influenc
infect
indirectli
enhanc
viru
adsorpt
onto
specif
cell
true
receptor
induc
conform
chang
viral
envgp
essenti
infect
howev
appear
intracellular
protein
role
control
viral
host
rang
protein
involv
traffic
intracellular
vesicl
like
endosom
play
critic
role
entri
therefor
protein
pathway
specif
character
might
consid
cofactor
role
mediat
direct
contact
envgp
crucial
entri
addit
virus
abl
use
one
endocyt
pathway
cellular
protein
involv
thu
direct
viru
entri
door
benefici
viru
particular
condit
pseudoparticl
retrovirida
core
incorpor
heterogen
envelop
protein
differ
viru
possibl
differ
famili
entri
process
mimic
precis
wildtyp
virus
envelop
glycoprotein
deriv
repres
use
tool
studi
molecular
process
envelop
virus
flexibl
allow
analysi
numer
mutant
moreov
allow
precis
measur
infect
depend
envelop
glycoprotein
entri
step
allow
establish
virusliposom
fusion
assay
first
introduc
envelop
architectur
structur
viral
fusion
machineri
develop
achiev
fusion
entri
step
despit
mani
differ
structur
share
common
refold
process
activ
differ
fusion
domain
found
fusion
protein
illustr
differ
fusion
regul
process
develop
virus
lead
function
virion
term
cleavag
activ
fusion
protein
exit
term
activ
bind
endocytosi
despit
differ
distinct
player
common
principl
propos
fusion
process
illustr
molecular
detail
character
matur
differ
fusion
protein
defin
follow
three
characterist
cleavag
envelop
protein
precursor
presenc
trigger
exposit
fusion
peptid
associ
trimer
complex
associ
activ
fusion
conform
progress
structur
rearrang
slow
kinet
barrier
hemifus
fusionpor
format
second
part
present
differ
entri
pathway
cell
protein
use
virus
infect
cell
virus
emerg
valuabl
tool
studi
endocyt
mechan
properti
crucial
develop
pseudoparticl
use
term
vector
gene
therapi
use
term
tool
receptor
clone
transgenesi
transduct
final
give
exampl
strategi
develop
vivo
vitro
inhibit
entri
step
envelop
virus
led
case
hiv
develop
inhibitor
use
clinic
membran
fusion
accord
stalkpor
model
envgp
respons
bring
membran
closer
trigger
link
destabil
outer
leaflet
merg
whole
membran
open
pore
cell
viru
membran
allow
core
enter
cytoplasm
cell
hypothesi
pore
model
viral
membran
fusion
mechan
support
experiment
result
first
evid
hemifus
intermedi
achiev
studi
influenza
viru
entri
occur
hemagglutinin
glycoprotein
bind
host
cell
substitut
hemagglutinin
transmembran
domain
glycosylphosphatidylinositol
gpi
reveal
import
transmembran
region
fusion
pore
open
expans
hemifus
structur
connect
outer
leaflet
appos
membran
wherea
inner
leaflet
remain
distinct
transient
structur
either
dissoci
give
rise
fusion
pore
chernomordik
kozlov
interestingli
helix
breaker
residu
within
tm
domain
critic
fusogen
differ
retrovir
env
hiv
owen
et
al
momlv
taylor
sander
import
hemifus
pore
open
step
fusion
process
addit
hemifus
intermedi
detect
case
hiv
envmedi
fusion
munozbarroso
et
al
use
peptid
inhibitor
target
prefus
prehairpin
structur
pore
form
allow
connect
two
compart
initi
separ
appos
membran
abil
membran
hemifus
develop
fusion
pore
found
depend
lipid
microdomain
composit
exampl
cholesterol
chernomordik
kozlov
inde
potenti
lipid
depend
viru
entri
process
first
deduc
experi
influenza
viru
impli
role
detergentresist
lipid
microdomain
takeda
et
al
retrovirus
tm
palmitoyl
contribut
env
local
detergentresist
lipid
microdomain
domain
li
et
al
indirectli
influenc
fusion
process
ochsenbauerjambor
et
al
altern
lipid
pore
hypothesi
direct
fusion
mechan
also
propos
fusion
pore
full
proteic
channellik
structur
depend
transmembran
domain
glycoprotein
model
pore
open
join
two
hemipor
locat
membran
kozlov
fusion
pore
open
enlarg
melikyan
et
al
genet
materi
enter
cytoplasm
cell
instig
viru
cell
cycl
fusion
virus
enter
directli
membran
plasmic
level
paramyxovirus
retrovirus
trigger
activ
viral
envelop
protein
neutral
ph
case
bind
viru
receptor
activ
fusogen
potenti
complex
envgp
mechan
phindepend
case
retrovirus
bind
surfac
subunit
su
receptor
induc
conform
chang
also
tm
interact
thu
induc
fusion
activ
neutral
ph
permit
envelop
glycoprotein
phindepend
virus
certain
experiment
condit
vivo
induc
fusion
cell
express
envelop
glycoprotein
cell
express
receptor
harrison
kielian
rey
weissenhorn
et
al
intercellular
fusion
merg
plasma
membran
place
cell
cytoplasm
continu
one
cell
becom
giant
multinucl
cell
name
syncytia
contrast
fusion
fig
virus
depend
strictli
intern
one
numer
endocyt
pathway
clathrindepend
clathrinindepend
caveolaeindepend
well
macropinocytosi
vaccinia
viru
mercer
heleniu
phagocytos
recent
describ
equin
herpesviru
viru
frampton
et
al
hiv
viru
trujillo
et
al
although
case
result
product
infect
marsh
heleniu
sieczkarski
whittak
figur
describ
far
envelop
virus
use
itinerari
fusion
reaction
requir
exposur
moder
acid
ph
differ
endocytosi
vesicl
phdepend
virus
classic
exampl
virus
fuse
low
ph
membran
endosom
artifici
membran
test
tube
includ
influenza
orthomyxoviru
dengu
tickborn
enceph
tbev
flavivirus
semliki
forest
alphaviru
sfv
harrison
kielian
rey
roch
et
al
weissenhorn
et
al
interestingli
intermedi
mechan
describ
two
retrovirus
asl
jsrv
propos
mechan
aslv
virion
entri
occur
two
step
involv
receptorprim
step
induc
env
conform
chang
thu
allow
env
becom
sensit
action
acid
ph
moth
et
al
hybrid
mechan
lead
cellcel
fusion
vivo
jsrv
also
use
receptor
prime
fusion
activ
jsrv
env
low
ph
mechan
differ
slightli
aslv
requir
dynaminassoci
endocytosi
bertrand
et
al
far
mani
differ
endocytosi
pathway
describ
marsh
heleniu
mercer
heleniu
mercer
et
al
use
phdepend
phindepend
virus
howev
reinvestig
entri
pathway
clearli
need
mani
phindepend
virus
origin
thought
reli
endocytosi
exampl
nipah
paramyxovirus
induc
fusion
cell
neutral
ph
consid
phindepend
viru
reliant
endocytosi
entri
howev
recent
propos
nipah
virus
niv
use
macropinocytosi
entri
pernet
et
al
note
virus
use
phindepend
mechan
activ
envgp
may
still
enter
cell
endocytosi
without
imper
requir
acidif
activ
envgp
endosom
clathrindepend
endocytosi
bestcharacter
pathway
entri
major
itinerari
entri
phdepend
virus
process
initi
format
characterist
invagin
membran
known
clathrinco
pit
ccp
fig
ccp
assembl
take
place
intern
face
plasma
membran
follow
signal
induc
activ
receptor
clathrindepend
method
intern
use
semliki
forest
sindbi
alphavirus
rubella
rubiviru
virus
exploit
differ
endocytosi
pathway
enter
host
cell
multipl
mechan
defin
pinocyt
involv
uptak
fluid
solut
small
particl
includ
clathrinmedi
macropinocytosi
caveolarraftmedi
mechan
well
sever
novel
mechan
larg
particl
taken
phagocytosi
process
restrict
cell
type
though
poorli
document
entri
virus
mediat
numer
cargo
endocytos
mechan
independ
clathrin
coat
protein
fission
gtpase
dynamin
pathway
includ
rhoa
pathway
pathway
geec
pathway
bind
particl
cell
surfac
entri
receptor
genet
materi
deliv
cytoplasm
cell
via
specif
endocytosi
pathway
recent
macropinocytosi
emerg
import
entri
pathway
virus
entri
phdepend
virus
mediat
use
clathrineco
endocyt
vesicl
virus
penetr
host
cell
via
format
vesicl
cover
caveola
molecul
use
pathway
viral
particl
target
neutral
ph
caveosom
earli
endosom
moder
acid
ph
altern
viru
use
nonclathrin
noncaveolindepend
pathway
dynamindepend
independ
pathway
differenti
implic
differ
gtpase
rhoa
differ
composit
cholesterol
flotillin
tem
etc
hantaan
hantaviru
exampl
detulleo
kirchhausen
heleniu
et
al
jin
et
al
kee
et
al
macropinocytosi
anoth
endocytosi
pathway
util
virus
belong
vaccinia
adeno
picorna
viru
famili
macropinocytosi
endocyt
mechan
normal
involv
fluid
uptak
induc
growth
factor
phorbol
ester
howev
bind
viru
particl
also
activ
signal
pathway
trigger
actinmedi
membran
ruffl
bleb
follow
format
larg
vacuol
macropinosom
plasma
membran
intern
viru
particl
penetr
virus
capsid
cytosol
limit
membran
macropinosom
mayor
pagano
mercer
heleniu
varieti
evid
suggest
macropinocytosi
mechan
epsteinbarr
herp
viru
entri
primari
cell
cell
line
marech
et
al
miller
huttfletch
base
defin
criteria
macropinocytosi
mercer
heleniu
conclus
probabl
prematur
may
depend
experiment
condit
use
concentr
virus
may
influenc
util
less
specif
pathway
note
differ
strain
viru
elicit
dramat
differ
respons
host
cell
entri
differ
macropinocyt
mechan
possibl
cell
line
subtl
differ
activ
ligand
mercer
et
al
addit
endocytosi
pathway
whilst
badli
defin
known
clathrinand
caveolaindepend
pathway
depend
differ
gtpase
cargo
protein
dynamin
rho
etc
defin
endocytosi
pathway
sever
virus
use
clathrinand
caveolaindepend
pathway
includ
influenza
orthomyxoviru
second
possibl
pathway
sarscov
coronaviru
lymphocyt
choriomening
arenaviru
lcmv
picornavirus
madshu
et
al
matlin
et
al
wang
et
al
final
vesicl
character
caveolin
caveosom
high
concentr
cholesterol
sphingolipid
clathrinindepend
dynamindepend
acid
compart
merg
earli
endosom
mayor
pagano
nonenvelop
viru
human
enterovirus
prototyp
phindepend
virus
use
endocytosi
pathway
far
two
envelop
virus
describ
use
pathway
newcastl
diseas
paramyxoviru
ndv
cantin
et
al
ebola
viru
empig
goldsmith
sanchez
virus
shown
use
one
entri
pathway
howev
recent
exampl
indic
virus
use
multipl
endocytosi
pathway
enter
target
cell
influenza
hiv
exampl
ebola
virus
known
enter
cell
clathrinmedi
endocytosi
sanchez
lipid
raftassoci
caveolinmedi
endocytosi
also
propos
mechan
ebola
viru
uptak
empig
goldsmith
term
activ
process
membran
fusion
need
particular
microdomain
alway
clear
virus
use
mani
differ
pathway
possibl
virus
evolv
fuse
intracellularli
select
advantag
releas
genom
specif
intracellular
site
allow
rapid
effici
establish
infecti
cycl
one
select
advantag
could
also
requir
particular
lipid
microdomain
like
enrich
cholesterol
inde
shown
contrari
class
ii
flaviviru
dengu
viru
yellow
fever
viru
fusion
protein
semliki
forest
viru
sfv
bind
cholesterol
explain
depend
cholesterol
compart
contain
cholesterol
umashankar
et
al
virus
depend
cholesterol
link
bulk
effect
membran
fluiditi
mainten
particular
microdomain
receptor
locat
particular
diffus
addit
dichotomi
phindepend
phdepend
fusion
process
plasma
endosom
membran
fusion
mechan
activ
fusion
protein
differ
envelop
virus
divers
reaction
fusion
trigger
interact
one
envelop
glycoprotein
uniqu
receptor
one
exampl
interact
envelop
glycoprotein
sutm
retroviru
multitransmembran
receptor
tabl
anoth
case
one
uniqu
envelop
glycoprotein
interact
sever
receptor
exampl
fusion
trigger
sequenti
interact
su
receptor
follow
interact
coreceptor
chimiokin
receptor
seven
transmembran
domain
hunter
previous
believ
bind
receptor
directli
trigger
seri
conform
chang
viral
envgp
culmin
fusion
viral
cellular
membran
howev
new
evid
suggest
retrovir
associ
receptor
trigger
obligatori
cooper
interact
crosstalk
envgp
viral
surfac
hiv
mlv
tailor
et
al
intermedi
step
prevent
infect
fail
convers
sever
circumst
crosstalk
induc
absenc
cell
surfac
receptor
viru
case
infect
proceed
effici
new
evid
strongli
impli
role
cell
surfac
receptor
infect
retrovirus
perhap
envelop
anim
virus
complex
interest
previous
imagin
case
envgp
doubl
function
attach
receptor
exclus
role
fusion
protein
howev
virus
two
function
fill
differ
protein
protein
neuropilin
hs
immun
recognit
tmd
chimiokin
receptor
tmd
napi
cotransport
tmd
napi
cotransport
tmd
napi
cotransport
tmd
gprotein
coupl
receptor
tmd
cotransport
naaa
neutr
tmd
sfv
alphaviru
bind
receptor
permit
endocytos
viru
compart
acid
ph
activ
protein
induc
fusion
tabl
paramyxovirus
includ
newcastl
parainfluenza
viru
human
parainfluenza
viru
type
mump
viru
bovin
rsv
brsv
ovin
rsv
orsv
human
rsv
hrsv
hypothesi
bind
hn
gsh
receptor
induc
conform
chang
receptor
also
f
protein
interact
chang
make
f
compet
membran
fusion
except
f
protein
simian
parainfluenza
viru
brsv
orsv
hrsv
strictli
requir
hn
gsh
induc
fusion
though
fusion
greatli
increas
hn
gsh
respect
complex
distribut
function
still
evid
exampl
alphaherpesviru
rey
case
bind
gd
glycoprotein
one
three
receptor
hvem
herpesviru
entri
molecul
mediat
nectin
specif
heparan
sulfat
activ
complex
gb
trimer
associ
gl
gh
protein
three
essenti
fusion
gianni
et
al
tabl
way
hepat
c
viru
heterodim
induc
entri
follow
recognit
least
four
receptor
claudin
ocludin
zeisel
et
al
anoth
interest
variat
activ
fusion
artifici
revers
process
case
describ
exosom
pseudoparticleincorpor
receptor
abl
enter
cell
express
envelop
exampl
multitransmembran
receptor
ectrop
murin
leukemia
viru
mlv
tva
receptor
avian
sarcomaleukosi
viru
aslva
use
infect
cell
express
respect
retrovir
envgp
balliet
bate
similarli
incorpor
one
coreceptor
human
immunodefici
viru
hiv
endr
et
al
endr
et
al
mebats
et
al
schnell
et
al
allow
product
viral
particl
infect
cell
express
simian
immunodefici
viru
siv
hiv
envelop
glycoprotein
interestingli
shown
nef
accessori
protein
human
immunodefici
viru
type
enhanc
infect
progeni
virion
express
virusproduc
cell
significantli
enhanc
infect
receptor
pseudotyp
cell
express
env
surprisingli
nef
also
increas
infect
particl
pseudotyp
tva
even
though
nef
effect
phdepend
env
protein
aslva
use
pseudotyp
pizzato
et
al
process
indic
differ
superfici
tension
cell
weak
radiu
cell
big
viru
strong
radiu
viru
small
crucial
develop
orient
fusion
process
envgp
one
side
receptor
said
cell
empti
bubbl
efficaci
fusion
process
regardless
membran
harbor
receptor
envgp
may
reflect
adapt
viru
optim
membran
merg
independ
superfici
tension
cell
complet
round
superfici
tension
depend
local
viru
bind
moreov
plasma
membran
differ
lipid
composit
interact
cytoskeleton
attenu
increas
superfici
tension
certain
local
structur
classif
class
class
ii
class
iii
fusion
protein
glycoprotein
envelop
virus
evolv
combin
two
main
featur
first
capac
bind
specif
cellular
receptor
second
includ
fusion
domain
peptid
fusion
transmembran
domain
activ
mediat
merg
fusion
viral
cellular
membran
three
differ
class
viral
fusion
protein
identifi
date
base
key
structur
featur
preand
postfus
stage
mani
studi
demonstr
structur
transit
preto
postfus
conform
lead
stabl
hairpin
conform
includ
class
fusion
protein
character
trimer
hairpin
contain
central
alphahel
coiledcoil
structur
class
ii
fusion
protein
character
trimer
hairpin
compos
beta
structur
third
class
fusion
protein
describ
recent
also
form
trimer
hairpin
combin
two
structur
element
alphahelix
betasheet
structur
roch
et
al
roch
et
al
synthesi
conform
class
ii
iii
fusion
protein
differ
class
viral
fusion
protein
divers
viru
famili
includ
retrovirida
filovirida
orthomyxovirida
paramyxovirida
coronavirida
differ
greatli
size
amino
acid
sequenc
membraneanchor
domain
share
common
structur
featur
essenti
membran
fusion
includ
two
heptad
repeat
call
preced
hydrophob
fusion
peptid
class
membranefus
reaction
mediat
refold
fusion
protein
highli
stabl
rodlik
structur
central
trimer
helic
coil
coil
coiledcoil
structur
emblemat
class
protein
physic
demonstr
comput
predict
structur
frequent
use
help
defin
fusion
protein
belong
class
envelop
glycoprotein
retroviru
gener
cleavag
precursor
one
su
one
transmembran
subunit
contain
anchor
sequenc
membran
hunter
matur
essenti
process
fusion
free
hydrophob
sequenc
n
termin
extrem
tm
name
fusion
peptid
suppos
insert
target
membran
initi
fusion
initi
fusion
peptid
mask
insid
trimer
envgp
form
compet
fusion
fig
gener
cleavag
fusion
protein
mandatori
class
protein
render
compet
fusion
earp
et
al
harrison
except
envelop
glycoprotein
ebola
sarscov
virus
classifi
class
ground
threedimension
structur
one
fragment
cleav
yet
function
though
ntermin
fusion
peptid
predict
potenti
transmembran
subunit
local
analog
homolog
virus
function
explain
also
presenc
intern
fusion
peptid
ebola
anoth
explan
function
requir
l
b
cathepsin
cleav
envgp
endocytosi
see
number
complex
surfac
virus
harbor
class
fusion
protein
variabl
seem
lentivirus
sutm
trimer
wherea
coronavirus
hundr
trimer
coat
surfac
give
characterist
morpholog
crown
origin
name
famili
tabl
process
assemblag
biosynthesi
class
viru
ii
differ
class
protein
kielian
rey
fig
biosynthesi
alphaviru
flaviviru
e
fusion
protein
fold
cotransl
companion
regulatori
protein
term
alphavirus
prm
flavivirus
heterodimer
interact
import
correct
fold
transport
fusion
protein
prm
cleav
cellular
proteas
furin
late
secretori
pathway
matur
reaction
crucial
regulatori
step
subsequ
viru
fusion
salminen
et
al
stadler
et
al
wengler
zhang
et
al
though
cleavag
envelop
glycoprotein
complex
import
contrari
class
fusion
protein
crucial
sinc
mutat
alphaviru
flaviviru
regul
protein
cleav
decreas
infect
salminen
et
al
zhang
et
al
case
sfv
alphaviru
fusion
process
induc
uncleav
fusion
protein
trigger
treatment
viru
less
rather
normal
fusion
threshold
ph
wildtyp
viru
salminen
et
al
zhang
et
al
variat
threshold
ph
fusion
necessari
dissoci
heterodim
class
ii
fusion
protein
either
homodim
heterodim
e
homodim
flavivirus
heterodim
alphavirus
form
envelop
net
viral
membran
lescar
et
al
rey
et
al
intern
fusion
peptid
mask
interfac
dimer
extrem
long
beta
sheet
one
import
differ
two
group
virus
bud
site
alphavirus
complex
transport
plasma
membran
heterodim
interact
maintain
process
new
virion
bud
plasma
membran
process
driven
later
contact
heterodim
matur
companion
protein
induc
requir
curvatur
lipid
bilay
combin
interact
cytosol
tail
nucleocapsid
bud
result
format
icosahedralenvelop
particl
triangul
contain
trimer
spike
contrast
flaviviru
particl
bud
endoplasm
reticulum
immatur
virion
form
trimer
prme
immatur
particl
organ
similar
matur
alphavirus
trimer
form
endosom
compart
expos
fusion
peptid
project
toward
top
glycoprotein
allow
initi
interact
target
membran
second
step
fold
back
ctermin
region
onto
trimer
ntermin
region
lead
format
postfus
protein
structur
third
final
step
also
requir
refold
membran
proxim
transmembran
region
order
obtain
fulllength
postfus
structur
membran
anchor
fusion
peptid
tm
domain
present
membran
three
differ
class
fusion
identifi
far
base
common
structur
motiv
class
fusion
protein
character
trimer
hairpin
contain
central
alphahel
coiledcoil
structur
retrovirus
receptor
bind
induc
movement
su
allow
looptohelix
transit
polypeptid
segment
tm
previous
buri
underneath
su
head
project
fusion
peptid
toward
target
membran
insert
irrevers
occur
springload
mechan
ctermin
end
green
long
tm
helix
jackknif
back
revers
direct
viralmembraneproxim
segment
tm
interact
antiparallel
fashion
groov
form
ntermin
blue
trimer
coil
coil
final
postfus
conform
tm
therefor
highli
stabl
rod
tm
fusionpeptid
segment
togeth
end
molecul
structur
term
trimer
hairpin
helix
buddl
hb
b
class
ii
fusion
protein
character
trimer
hairpin
compos
beta
structur
red
yellow
blue
part
subunit
correspond
respect
domain
ii
iii
ectodomain
fusion
loop
tip
domain
ii
monomer
transit
prefus
dimer
trimericextend
intermedi
shown
exposur
low
ph
endosom
domain
ii
swing
outward
domain
iii
stem
remain
orient
membran
roughli
similar
prefus
state
fusion
loop
top
diagram
interact
target
bilay
domain
ii
associ
trimer
core
postfus
conform
domain
iii
must
zip
back
along
trimer
core
thu
reorient
domain
iii
c
third
class
fusion
protein
describ
recent
also
form
trimer
hairpin
combin
two
structur
element
alphahelix
betasheet
structur
class
iii
fusion
protein
compos
five
domain
give
rise
molecular
architectur
distinct
report
class
class
ii
fusion
protein
interestingli
ectodomain
g
crystal
pre
postfus
lowph
state
conform
chang
occur
upon
low
ph
exposur
domain
g
radic
chang
posit
orient
result
rearrang
occur
linker
region
domain
yellow
carri
fusion
loop
transmembran
domain
move
nm
one
end
molecul
opposit
domain
iii
blue
undergo
signific
refold
extens
central
helix
f
complet
process
ctermin
helic
domain
iv
red
insert
crevic
form
two
protom
postfus
form
reminisc
structur
chang
observ
refold
event
class
fusion
protein
hb
format
spike
prm
cover
fusion
protein
e
newli
form
virion
transport
extern
milieu
exocyt
pathway
process
prm
gener
matur
protein
short
residu
ectodomain
kuhn
et
al
zhang
et
al
presum
remov
larg
portion
prm
ectodomain
flaviviru
surfac
dramat
reorgan
process
give
ee
homodim
arrang
icosahedr
symmetri
matur
flaviviru
particl
display
smooth
spikeless
surfac
e
dimer
order
characterist
her
bone
pattern
correl
criteria
class
class
iii
fusion
protein
virus
harbor
class
ii
fusion
protein
phdepend
final
four
class
iii
fusion
protein
resolv
vsvg
gb
ebv
baculoviru
spite
homolog
trimer
structur
major
function
differ
aris
differ
biosynthesi
g
protein
class
iii
fusion
protein
whose
prefus
structur
known
protein
class
fusion
iii
combin
two
structur
element
alpha
helix
like
class
beta
sheet
like
class
ii
heldwein
et
al
kadlec
et
al
roch
et
al
roch
et
al
fig
trimer
maintain
interact
central
alpha
helix
domain
fusion
expos
two
buckl
intern
fusion
peptid
place
extrem
long
beta
sheet
g
protein
protein
respons
bind
entri
vsv
rhabdoviru
vsv
possess
molecul
g
protein
surfac
form
trimer
contrast
viru
incorpor
differ
envgp
surfac
essenti
entri
step
gd
gb
ghgl
turner
et
al
biosynthesi
neither
g
protein
vsv
gb
cleav
present
intern
fusion
peptid
howev
wherea
g
function
gb
envelop
glycoprotein
alon
suffici
induc
entri
viru
membran
fusion
nevertheless
current
precis
interact
gd
gb
ghgl
identifi
even
though
gd
ectodomain
shown
allow
entri
engin
viru
particl
lack
gd
gdnull
mutant
cocchi
et
al
major
compon
viral
envelop
sole
fusogen
protein
trigger
induc
fusion
low
ph
environ
endosom
baculoviru
interestingli
distinguish
featur
g
fusion
protein
undergo
revers
conform
chang
unlik
class
class
ii
fusion
protein
postfus
conform
thermodynam
stabl
ph
valu
conform
rearrang
effect
irrevers
vsv
exposur
low
ph
inactiv
viru
fusion
activ
fulli
recov
ph
rais
propos
revers
conform
chang
allow
g
avoid
unspecif
activ
transport
acid
golgi
vesicl
seen
previou
section
though
much
describ
variat
manner
activ
fusion
protein
addit
mechan
await
discoveri
three
class
fusion
protein
defin
far
weissenhorn
et
al
previous
describ
base
main
structur
organ
envgp
virus
assign
class
ii
iii
parallel
base
activ
mechan
fusion
protein
virus
classifi
phdepend
independ
interestingli
relationship
mechan
activ
fusion
class
protein
fusion
correl
hiv
influenza
envgp
class
yet
process
activ
phindepend
depend
respect
entri
viru
similarli
class
iii
fusion
protein
enclos
herp
viru
simplex
gb
protein
rhabdoviru
vsvg
protein
phindepend
phdepend
respect
activ
far
class
ii
fusion
protein
phdepend
activ
although
notabl
differ
activ
process
structur
motiv
use
initi
oligomer
state
fusion
protein
nativ
trimer
conform
class
iii
protein
opposit
homoor
heterodim
class
ii
fusion
protein
common
featur
final
structur
obtain
fusion
seem
suggest
gener
mechan
conform
chang
common
envgp
envelop
virus
see
fig
first
activ
fusion
protein
follow
interact
cellular
receptor
coupl
exposur
acid
environ
endosom
expos
fusion
peptid
project
toward
top
glycoprotein
allow
initi
interact
cellular
target
membran
class
fusion
protein
propos
model
indic
transit
conform
requir
transform
part
molecul
alpha
helix
associ
three
helix
bundl
name
coil
coil
weissenhorn
et
al
retrovirus
movement
allow
looptohelix
transit
polypeptid
segment
tm
previous
buri
underneath
su
head
project
fusion
peptid
toward
target
membran
insert
irrevers
case
class
fusion
protein
like
retrovirus
occur
springload
mechan
initi
chang
propos
result
prehairpin
intermedi
extend
structur
anchor
target
membran
fusion
peptid
viru
membran
tm
transmembran
segment
class
ii
fusion
protein
project
fusion
peptid
requir
dissoci
heteroor
homodim
modif
hing
region
unstructur
conform
chang
stiasni
heinz
class
iii
roch
et
al
similarli
fusion
protein
class
exhibit
fusion
peptid
requir
rearrang
domain
mediat
modif
central
helix
remain
parallel
second
fold
back
region
includ
fusion
peptid
onto
trimer
ctermin
region
lead
format
postfus
protein
structur
outer
region
zip
inner
trimer
core
interestingli
describ
class
ii
iii
peptid
inhibit
step
compet
interact
envgpspecif
domain
format
structur
third
final
step
requir
refold
juxtamembran
transmembran
region
obtain
stabl
postfus
structur
fusion
peptid
transmembran
domain
extrem
stabl
stem
protein
complex
anchor
target
membran
structur
bring
two
membran
proxim
provid
free
energi
overcom
barrier
membran
merg
melikyan
membran
fusion
occur
lead
pore
format
releas
viral
genom
cytoplasm
refold
class
ii
fusion
protein
gener
trimer
monomer
intermedi
exist
monomer
intermedi
class
iii
well
known
howev
step
led
exposit
fusion
peptid
interact
membran
target
maintain
threeorder
symmetri
refold
ctermin
region
requir
destruct
trimer
least
juxtamembran
region
moreov
differ
observ
amino
acid
involv
interfac
reconstitut
resolv
trimer
preand
postfus
conform
probabl
conform
chang
go
monomer
intermedi
class
iii
g
envelop
glycoprotein
vsv
class
f
protein
paramyxoviru
contrari
interfac
class
subunit
ha
envelop
glycoprotein
trimer
similar
preand
postfus
conform
shed
doubt
exist
monomer
intermedi
contrast
fusion
initi
low
ph
dimer
class
ii
fusion
protein
broken
free
monom
reassoci
trimer
final
precis
structur
inform
nativ
metast
conform
prefus
final
stabl
conform
postfus
avail
limit
number
virus
envelop
glycoprotein
influenza
viru
sfv
tbev
vsv
parainfluenza
f
protein
structur
convers
nativ
metast
conform
final
stabl
conform
precis
known
highli
specul
virus
envelop
glycoprotein
domain
impli
molecular
rearrang
littlereferenc
clearli
studi
necessari
identifi
intermediari
envelop
glycoprotein
conform
intermedi
would
identifi
domain
interact
conform
chang
highlight
way
gener
inhibitori
peptid
f
domain
organizationsfus
domain
acquisit
fusion
compet
prime
cleavag
viru
product
host
cell
basic
preserv
sinc
express
fusogen
compet
glycoprotein
highli
control
virus
howev
virus
envgp
induc
cytopath
effect
lead
gener
multinucl
cell
call
syncytia
induc
fusion
cell
express
envelop
glycoprotein
receptor
abund
glycoprotein
surfac
cell
could
induc
cellular
death
syncytia
format
toxic
via
receptor
interact
immun
recognit
reason
local
amount
oligomer
envelop
glycoprotein
host
cellular
surfac
highli
modul
fine
traffick
sequestr
mechan
receptor
interfer
mechan
either
satur
bind
site
receptor
envelop
glycoprotein
intern
receptor
differ
viral
protein
achiev
retrovirus
hunter
also
limit
amount
receptor
avail
fusion
infect
cell
control
cleavag
envgp
free
fusion
peptid
also
regul
process
fusion
protein
fusogen
labont
seidah
final
envgp
fusion
compet
may
late
event
occur
viru
bud
describ
mulv
retrovirus
rein
et
al
proteolyt
prime
common
method
control
activ
membran
fusion
mediat
viral
glycoprotein
member
proprotein
convertas
pc
famili
play
central
role
process
andor
activ
variou
protein
precursor
involv
mani
physiolog
process
variou
patholog
neurodegen
patholog
cancer
bacteri
toxin
activ
viral
infect
proteolysi
precursor
occur
basic
residu
within
gener
motif
kr
x
kr
mediat
proprotein
convertas
furin
also
call
also
call
lpc
wherea
proteolysi
precursor
within
hydrophob
residu
perform
convertas
convertas
seem
prefer
cleav
lvfaqsip
motif
lahlil
et
al
seven
pc
differ
albeit
partli
overlap
express
pattern
subcellular
local
conserv
aminotermini
highest
homolog
subtilisinlik
catalyt
domain
data
variou
infecti
virus
reveal
cleavag
envelop
glycoprotein
precursor
one
pc
requir
step
acquisit
infecti
capac
viral
particl
inde
variou
studi
demonstr
capac
pc
correctli
cleav
varieti
viral
surfac
glycoprotein
includ
decroli
et
al
surfac
glycoprotein
hong
kong
ebola
viru
sever
acut
respiratori
syndrom
coronaviru
chikungunya
viru
basak
et
al
bergeron
et
al
ozden
et
al
parallel
studi
reveal
inhibit
process
viral
surfac
glycoprotein
pc
inhibitor
decrvkrcmk
complet
abrog
virusinduc
cellular
cytopath
surfac
glycoprotein
virus
particularli
hemorrhag
fever
virus
arenavirida
famili
lassa
basak
et
al
lenz
et
al
crimean
congo
hemorrhag
fever
vincent
et
al
lymphocyt
choriomening
beyer
et
al
shown
cleav
convertas
cleav
hydrophob
residu
similarli
block
activ
specif
inhibitor
also
shown
affect
process
stabil
glycoprotein
virus
pullikotil
et
al
highli
pathogen
avian
influenza
hpai
virus
subtyp
known
date
cleavag
ha
occur
ctermin
r
residu
consensu
multibas
motif
rxkrr
r
posit
kkrktr
k
lead
system
infect
earli
studi
demonstr
ubiquit
express
furin
proprotein
convertas
pc
activ
proteas
hpai
virus
basak
et
al
stienekegrob
et
al
recent
ubiquit
type
ii
transmembran
serin
proteas
mspl
splice
variant
propos
novel
candid
proteas
process
ha
protein
hpai
okumura
et
al
interest
note
viral
receptor
also
modifi
proprotein
convertas
inde
imped
hepat
c
viru
infect
vitro
modul
liver
express
enhanc
degrad
lowdens
lipoprotein
receptor
ldlr
labont
et
al
bestow
proprotein
convertas
addit
role
control
fusogen
envelop
glycoprotein
exhibit
insert
hydrophob
fragment
residu
membran
name
fusion
peptid
fusion
loop
crucial
step
fusion
process
epand
fusion
peptid
ntermin
posit
retroviru
influenza
viru
liber
virus
envelop
glycoprotein
cleavag
insert
extern
layer
membran
obliqu
manner
wherea
fusion
loop
class
ii
iii
virus
remain
probabl
superfici
see
tabl
fusion
peptid
class
ii
protein
initi
buri
envelop
glycoprotein
trimer
dimer
respect
class
iii
fusion
loop
present
outsid
structur
like
fusion
peptid
class
iii
fusion
protein
weakli
hydrophob
probabl
requir
cooper
sever
loop
function
effici
simpl
pictur
viral
fusion
protein
act
cell
viral
membran
mean
two
restrict
segment
say
fusion
peptid
transmembran
domain
simplist
instead
complex
concert
action
differ
membranotrop
segment
fusion
protein
necessari
conform
chang
requir
achiev
complet
fusion
two
lipid
bilay
describ
previous
class
iiii
fusion
protein
roughli
share
common
refold
process
format
intermedi
sever
region
fusion
protein
complex
indirectli
aid
fusion
process
exampl
stem
region
see
contrari
rel
simpl
canon
organ
fusion
peptid
influenza
viru
flaviviru
e
protein
recent
resolv
structur
gb
glycoprotein
simplex
herp
type
viru
heldwein
et
al
g
protein
roch
et
al
roch
et
al
vesicular
stomat
viru
vsv
indic
bipartit
fusion
peptid
compos
two
hydrophob
loop
loop
rel
nonpolar
weakli
hydrophob
rare
lead
identif
fusion
peptid
fusion
peptid
predict
base
hydrophob
domain
identif
differ
organ
fusion
peptid
suggest
differ
action
fusion
protein
notabl
number
requir
accord
experi
use
neutral
assay
seem
one
hiv
envelop
glycoprotein
capabl
induc
membran
fusion
howev
shown
induc
fusion
ha
requir
collabor
sever
complex
envelop
glycoprotein
trimer
way
differ
network
class
ii
fusion
protein
propos
hexagon
organ
observ
surfac
liposom
associ
five
trimer
structur
similar
volcano
base
structur
predict
stiasni
heinz
concern
fusion
protein
class
iii
hexagon
structur
propos
rabi
viru
envelop
glycoprotein
recent
vsvg
accord
model
use
structur
requir
multipl
fusion
peptid
may
compar
number
receptor
requir
assembl
complex
contain
sever
receptor
may
prerequisit
membran
fusion
step
requir
multipl
envgp
molecul
cooper
particip
process
exampl
case
presenc
one
contact
viru
enhanc
infect
dramat
reduc
concentr
coreceptor
need
infect
platt
et
al
investig
system
impli
critic
complex
contain
approxim
four
six
coreceptor
requir
infect
although
known
whether
complex
perform
transient
role
dispers
maintain
throughout
membran
fusion
process
kuhmann
et
al
despit
uncertainti
sever
line
evid
suggest
three
six
hemagglutin
trimer
may
cooper
particip
influenza
virusmedi
membran
fusion
reaction
blumenth
et
al
boulay
et
al
multipl
envelop
glycoprotein
trimer
requir
rabi
virusmedi
membran
fusion
roch
gaudin
see
tabl
cytoplasm
tail
envelop
virus
harbor
differ
motif
respons
traffick
variabl
length
surpris
see
cytoplasm
tail
fusion
protein
exchang
exampl
hcv
cytoplasm
tail
f
cytoplasm
tail
hrsv
human
respiratori
syncyti
viru
substitut
vsvg
envelop
glycoprotein
fusogen
envelop
cellcel
fusion
assay
viruscel
assay
infect
destroy
buonocor
et
al
oomen
et
al
similarli
ha
glycoprotein
anchor
gpi
entri
process
stop
hemifus
step
kembl
et
al
markosyan
et
al
cellular
local
eg
cholesterolrich
microdomain
sometim
modifi
biochem
modif
glycosyl
oligomer
affect
properti
vsvg
envgp
kembl
et
al
nevertheless
initi
context
cytoplasm
tail
allow
fusion
virus
regul
fusion
mediat
cleavag
cytoplasm
tail
retroviru
addit
sutm
cleavag
signific
fraction
virionassoci
tm
process
viral
proteas
remov
ctermin
amino
acid
cytoplasm
domain
r
peptid
retroviru
virion
assembl
bud
infect
cell
immatur
particl
must
undergo
addit
proteolyt
matur
becom
infecti
green
et
al
lavillett
et
al
lavillett
et
al
rein
et
al
matur
concern
viral
proteasedepend
cleavag
socal
peptid
r
cterminu
cytoplasm
tail
r
peptid
inhibit
fusion
differ
hypothesi
propos
first
r
peptid
contain
yxxintern
motif
remov
motif
follow
cleavag
r
peptid
might
result
higher
amount
envelop
surfac
membran
thu
fusion
song
et
al
second
follow
r
peptid
cleavag
remain
cyt
tail
form
membraneembed
amphiphil
alphahelix
domain
destabil
membran
rozenbergadl
et
al
zhao
et
al
third
propos
r
peptid
contain
palmitoyl
remov
induc
close
trimer
cyt
tail
drastic
conform
chang
ectodomain
env
aguilar
et
al
might
influenc
env
fusogen
destabil
sutm
complex
conform
chang
necessari
isomer
sutm
disulfid
mlv
env
love
et
al
r
peptid
cleavag
last
step
lead
fusion
compet
infecti
mlv
retroviru
final
modif
exist
lentivirus
harbor
long
cytoplasm
tail
howev
truncat
long
cytoplasm
domain
lentivir
env
protein
occur
certain
cultur
condit
chakrabarti
et
al
increas
env
fusogen
similar
way
mutat
truncat
version
siv
env
mulligan
et
al
spi
et
al
wilk
et
al
regul
hallmark
adapt
endogen
retrovirus
cleavag
fulfil
cellular
proteas
activ
endogen
envgp
hervw
relev
tissu
involv
placenta
develop
interest
note
virus
retroviru
truncat
cytoplasm
tail
increas
fusogen
envgp
seen
paramyxovirus
moll
et
al
mani
case
truncat
seem
increas
cell
surfac
express
sinc
cellular
traffick
signal
cytoplasm
tail
modifi
may
explain
increas
fusogen
certain
env
truncat
lead
conform
chang
ectodomain
lower
activ
threshold
fusion
result
enhanc
env
fusion
activ
kinet
aguilar
et
al
cote
et
al
spi
et
al
zhao
et
al
final
cleavag
cytoplasm
tail
sometim
allow
least
partial
cellcel
fusion
neutral
ph
phindepend
although
entri
viru
remain
phdepend
notion
phdepend
seem
case
due
specif
conform
particular
densiti
envelop
glycoprotein
numer
studi
sever
virus
highlight
critic
role
pretransmembran
sequenc
ptm
also
call
membran
proximal
region
juxtamembran
domain
jmd
rich
aromat
amino
acid
class
fusion
glycoprotein
coronaviru
lentiviru
hiv
siv
fiv
ebola
viru
munoz
barroso
et
al
saezcirion
et
al
mani
virus
contain
short
jmd
region
ectodomain
end
begin
transmembran
tm
domain
class
ii
sfv
dengu
tebv
class
iii
vsv
herp
viru
fusion
protein
also
possess
region
although
less
rich
tryptophan
class
jmd
jeetendra
et
al
jeetendra
et
al
roch
et
al
although
jmd
fusion
protein
envelop
virus
rich
aromat
amino
acid
number
space
sequenc
aromat
amino
acid
quit
variabl
howev
function
remain
jmd
contribut
conform
chang
occur
membran
fusion
interact
membran
induc
membran
destabil
andor
facilit
membran
fusion
munozbarroso
et
al
therefor
jmd
viral
fusion
protein
potenti
target
viral
inhibitor
entri
inhibitor
target
jmd
class
fusion
protein
includ
monoclon
antibodi
bind
jmd
fiv
hiv
loriz
et
al
purtscher
et
al
peptid
mimic
jmd
design
envgp
fiv
giannecchini
et
al
hiv
moreno
et
al
ebola
viru
saezcirion
et
al
sar
viru
howard
et
al
inhibit
viral
entri
strategi
also
broadli
use
mani
paramyxovirus
sendai
viru
joshi
et
al
rapaport
et
al
newcastl
diseas
viru
young
et
al
human
parainfluenza
type
yao
compan
respiratori
syncyti
viru
rsv
measl
viru
mv
lambert
et
al
way
peptid
mimic
jmd
class
ii
iii
fusion
protein
also
develop
infect
dengu
viru
hrobowski
et
al
cmv
english
et
al
lopper
compton
case
hcv
juxtamembran
domain
propos
drummer
poumbourio
drummer
et
al
highthroughput
screen
ht
peptid
deriv
sequenc
identifi
inhibitori
peptid
close
transmembran
domain
though
among
inhibitori
cheng
et
al
howev
strategi
suffer
certain
limit
deriv
peptid
jmd
often
capac
oligomer
inactiv
stratagem
need
implement
make
peptid
bioreact
virus
moreov
peptid
prevent
correct
conform
chang
envelop
glycoprotein
must
act
certain
window
time
particular
compart
compat
activ
structur
inde
acid
ph
compart
compat
bioactiv
structur
peptid
sarscov
viru
peptid
abl
inhibit
entri
viru
presenc
proteas
cellular
surfac
peptid
littl
effect
entri
viru
endocytosi
activ
cathepsin
l
acid
condit
endosom
ujik
et
al
case
influenza
possibl
develop
inhibitori
peptid
target
juxtamembran
domain
reason
suggest
includ
entri
acid
compart
modifi
protein
structur
entri
differ
pathway
endocytos
rapid
conform
chang
ha
modif
made
peptid
increas
effici
virus
fuse
plasma
membran
three
paramyxovirus
major
caus
lower
respiratori
tract
diseas
infant
emerg
zoonot
virus
hendra
viru
hev
niv
caus
lethal
central
nervou
system
cn
diseas
addit
cholesterol
paramyxoviru
hrcderiv
peptid
deriv
heptad
repeat
immedi
preced
transmembran
domain
increas
antivir
potenc
log
unit
porotto
et
al
enhanc
activ
result
target
peptid
plasma
membran
cholesteroltag
peptid
cell
surfac
creat
protect
antivir
shield
target
f
protein
directli
site
action
expand
potenti
util
inhibitori
peptid
paramyxovirus
definit
receptor
complic
limit
sometim
difficult
distinguish
simpl
receptor
mediat
adsorpt
bind
may
even
initi
conform
chang
critic
receptor
fusion
upon
bind
gener
conform
chang
allow
exposur
fusion
peptid
lead
membran
fusion
cellular
molecul
also
involv
local
traffick
viral
receptor
import
cofactor
entri
anoth
ambigu
role
enzymat
activ
necessari
process
fusion
protein
insid
produc
cell
insid
endosom
target
cell
necessari
activ
potenti
envgp
membran
fusion
inaccur
consid
receptor
certainli
critic
cofactor
virus
like
bind
least
weakli
multipl
cell
surfac
compon
heparan
sulfat
proteoglycan
dcsign
integrin
glycolipid
bounou
et
al
cantin
et
al
fortin
et
al
jinnoou
et
al
mondor
et
al
saphir
et
al
saphir
et
al
although
bind
substanc
probabl
induc
conform
chang
envgp
necessari
membran
fusion
enhanc
viral
adsorpt
substanti
increas
effici
infect
thu
contribut
pathogenesi
alvarez
et
al
bounou
et
al
geijtenbeek
et
al
jinnoou
et
al
saphir
et
al
bind
protein
contribut
infect
difficult
unambigu
distinguish
receptor
directli
mediat
membran
fusion
process
especi
virus
bind
authent
receptor
weakli
eg
retrovirus
case
felvt
polytrop
mulv
anderson
et
al
marin
et
al
temin
emphas
pathogen
variant
differ
anim
virus
often
associ
abil
bind
appar
novel
cell
surfac
compon
sometim
infer
virus
switch
receptor
specif
instanc
gener
establish
cell
surfac
bind
compon
receptor
directli
mediat
infect
case
ebola
exampl
receptor
mediat
entri
yet
definit
identifi
ctype
lectin
dcsign
dcsignr
thought
serv
adher
factor
ebola
marburg
viru
marzi
et
al
matsuno
et
al
plasma
membraneassoci
protein
implic
ebov
uptak
includ
folat
receptor
alpha
tyrosin
kinas
receptor
axl
chan
et
al
shimojima
et
al
shimojima
et
al
sinn
et
al
physic
interact
ebov
gp
protein
demonstr
cell
express
protein
permiss
ebov
gpmediat
virion
uptak
previou
studi
implic
actin
cytoskeleton
ebov
entri
agent
cytochalasin
swinholid
impair
microfila
function
inhibit
gpmediat
entri
yonezawa
et
al
similarli
vsv
shown
bind
ubiquit
cell
via
phosphatidylserin
ps
schlegel
et
al
howev
recent
studi
report
ps
receptor
vsv
correl
found
cell
surfac
ps
level
vsv
infect
annexin
v
specif
bind
ps
inhibit
infect
vsv
coil
miller
therefor
cell
surfac
receptor
vsv
identifi
gener
thought
bind
via
gprotein
rather
unspecif
involv
neg
charg
plasma
membran
carneiro
et
al
coil
miller
adsorpt
virus
onto
cultur
cell
medium
usual
slow
ineffici
process
princip
slow
rate
diffus
contact
cell
surfac
allison
valentin
andreadi
et
al
gener
rate
contact
significantli
enhanc
mix
stir
boundari
layer
rel
stationari
fluid
surround
wall
larg
object
eg
cell
flow
liquid
substanti
compar
rate
viru
diffus
henc
stir
increas
concentr
viru
surround
boundari
zone
allison
valentin
case
retrovirus
becom
especi
clear
adsorpt
sever
limit
step
infect
cultur
cell
classic
studi
viru
sampl
incub
cell
sever
hour
wash
fresh
medium
subsequ
detect
foci
infect
estim
fewer
virion
medium
infecti
contrast
previou
interpret
studi
suggest
low
infectivitytovirion
ratio
princip
caus
ineffici
adsorpt
andreadi
et
al
accordingli
serial
incub
viruscontain
medium
period
sequenti
cell
cultur
result
titer
cultur
correct
spontan
viral
decay
kabat
et
al
furthermor
centrifug
viru
onto
cultur
cell
ie
spinocul
often
increas
retrovir
titer
log
order
magnitud
bahnson
et
al
studi
aim
count
retrovirion
adsorb
onto
cell
surfac
confoc
immunofluores
microscopi
quantit
pcr
method
marech
et
al
pizzato
et
al
pizzato
et
al
demonstr
receptor
viral
entri
irrelev
initi
adsorpt
retrovirion
onto
surfac
cell
pizzato
et
al
pizzato
et
al
contrari
initi
step
viru
attach
seem
critic
depend
accessori
cellular
bind
substanc
heparin
sulfat
integrin
lectin
includ
dcsign
bounou
et
al
guibinga
et
al
jinnoou
et
al
mondor
et
al
saphir
et
al
form
multival
weak
revers
bond
abund
cell
surfac
compon
viru
would
becom
effici
bound
manner
would
allow
graze
make
appropri
contact
true
receptor
haywood
park
et
al
well
known
sever
virus
rubella
togaviru
bvdv
pestiviru
newcastl
diseas
paramyxoviru
hiv
lentiviru
mous
hepat
coronaviru
mhv
rearrang
thiol
content
disulfid
bridg
induc
thioredoxin
protein
disulfid
isomeras
pdi
essenti
induc
big
conform
chang
necessari
membran
fusion
fenouillet
et
al
interestingli
mlv
htlv
retrovirus
develop
intern
oxydoreduct
activ
adapt
catalyt
motif
involv
disulfur
bridg
isomer
two
su
tm
subunit
link
either
coval
noncoval
manner
exist
solubl
protein
indic
noncoval
link
su
tm
kowalski
et
al
howev
retrovirus
coval
link
describ
one
stage
case
except
mmtv
jsrv
disulfid
bond
su
tm
form
highli
conserv
motif
tm
cxxc
su
pinter
et
al
schulz
et
al
sitbon
et
al
cxxc
motif
extrem
rare
cellular
protein
similar
motif
found
catalyt
site
enzym
involv
thiol
isomer
like
pdi
thioredoxin
pinter
et
al
sander
motif
su
shown
part
autocatalyt
isomer
function
su
destroy
initi
bond
su
tm
gener
env
synthesi
creat
intrasu
bond
insid
cxxc
motif
wallin
et
al
disulfid
bond
isomer
crucial
fusogen
retroviru
mlv
fenouillet
et
al
virus
use
proteas
activ
particular
cellular
enzym
local
endosom
cellular
surfac
activ
envgp
ebola
filoviru
envelop
glycoprotein
cleav
furin
produc
cell
chandran
et
al
schornberg
et
al
hev
pager
dutch
niv
diederich
et
al
sarscov
coronavirus
spike
cleav
produc
cell
huang
et
al
qiu
et
al
simmon
et
al
requir
cystein
lysosom
proteas
l
b
cathepsin
catl
catb
entri
process
viru
uptak
follow
angiotensinconvert
enzym
receptor
bind
cathepsin
lmediat
proteolysi
induc
conform
chang
sarscov
glycoprotein
trigger
endosom
membran
fusion
process
simmon
et
al
likewis
cleavag
ebola
glycoprotein
catl
cleavag
remov
glycosyl
glycan
cap
mucinlik
domain
muc
domain
expos
conserv
core
residu
implic
receptor
bind
chandran
et
al
hood
et
al
lee
et
al
schornberg
et
al
entri
viru
phdepend
associ
cleavag
gp
proteas
includ
catl
andor
catb
endosom
cell
membran
requir
entri
host
cell
howev
precis
role
cleavag
ebola
envelop
glycoprotein
alreadi
cleav
intracellularli
exit
uncertain
cleavag
gp
stabl
form
kda
may
increas
bind
suggest
cleavag
facilit
interact
cellular
receptor
dube
et
al
kaletski
et
al
anoth
possibl
catb
cleavag
requir
facilit
trigger
viral
membran
fusion
destabil
prefus
conform
ebola
envelop
glycoprotein
wong
et
al
cathepsin
compris
famili
lysosom
proteas
enzym
whose
primari
function
ie
protein
degrad
play
critic
role
normal
cellular
homeostasi
cathepsin
l
one
member
human
lysosom
cystein
proteas
ie
b
c
f
h
k
l
v
w
x
fall
famili
papain
famili
ca
clan
rossi
et
al
enzym
tradit
link
nonspecif
proteolyt
activ
within
lysosom
recent
cathepsin
l
implic
regulatori
event
relat
cancer
diabet
immunolog
respons
degrad
articular
cartilag
matrix
patholog
process
vasiljeva
et
al
includ
osteoporosi
rheumatoid
arthriti
tumor
metastasi
palermo
joyc
interestingli
sever
host
cell
proteas
appear
abl
prime
fusion
activ
case
sarscov
includ
cathepsin
l
trypsin
factor
xa
thermolysin
plasmin
elastas
proteolyt
cleavag
event
sarscov
lead
membran
fusion
occur
boundari
adjac
fusion
peptid
domain
belouzard
et
al
elastasemedi
activ
sarscov
origin
report
taguchi
cowork
propos
elastas
may
import
implic
viral
pathogenesi
matsuyama
et
al
elastas
known
secret
neutrophil
part
inflammatori
respons
viral
infect
also
produc
opportunist
bacteria
eg
pseudomona
aeruginosa
colon
viral
infect
respiratori
tissu
consid
elastasemedi
activ
sarscov
might
import
factor
sever
pneumonia
seen
sarscovinfect
patient
belouzard
et
al
conclus
order
better
classifi
receptor
receptor
must
differenti
accord
precis
function
permit
nonspecif
adsorpt
glycosaminoglycan
use
dengu
tbe
type
c
lectin
receptor
lsign
dcsign
hmgl
lsectin
asialoglycoprotein
receptor
use
hcv
ebola
marburg
permit
specif
adsorpt
receptor
bind
receptor
allow
sort
toward
particular
endosom
intracytoplasm
compart
initi
conform
chang
hiv
integrin
laminin
receptor
dengu
sindbi
lassa
virus
final
permit
exposit
domain
implic
destabil
membran
like
fusion
peptid
latest
receptor
act
hiv
coreceptor
therefor
studi
kinet
conform
chang
envgp
kinet
action
util
receptor
essenti
accur
categor
receptor
nonspecif
adsorpt
receptor
receptor
bind
receptor
fusion
cellular
protein
allow
exposit
local
traffick
receptor
andor
endosom
consid
cofactor
sirna
screen
come
list
cofactor
dramat
increas
use
differ
receptor
often
correl
need
viru
overcom
barrier
exist
cell
type
tissu
infect
one
wellstudi
exampl
bind
coxsackieviru
b
decayacceler
factor
daf
apic
surfac
epitheli
cell
subsequ
coxsackieviru
adenoviru
receptor
car
local
tight
junction
region
daf
help
bring
viru
tight
junction
car
induc
conform
chang
promot
endocytosi
coyn
bergelson
almost
anim
virus
use
receptor
exclus
contain
singl
tm
sequenc
see
tabl
strike
contrast
cell
surfac
receptor
retrovirus
multipl
transmembran
tm
sequenc
compat
identif
known
instanc
transport
import
solut
similarli
hepat
c
viru
addit
ldl
receptor
exclus
use
multitransmembran
receptor
scaveng
receptor
class
b
type
two
transmembran
domain
tetraspanin
receptor
claudin
tm
anoth
tight
junction
protein
transmembran
domain
anoth
surpris
virus
includ
mani
retrovirus
use
one
receptor
pair
close
relat
receptor
altern
tailor
et
al
appear
enhanc
viral
surviv
sever
limit
likelihood
host
escap
mutat
receptor
use
retrovirus
contain
hypervari
region
often
heavili
glycosyl
control
viral
host
rang
properti
consist
idea
sequenc
battleground
virushost
coevolut
howev
contrast
previou
assumpt
probabl
retrovirus
adapt
recogn
conserv
site
import
receptor
natur
function
hypervari
sequenc
elabor
host
defens
bulwark
surround
conserv
viral
attach
site
fact
viru
group
sever
limit
throughout
evolut
type
receptor
employ
may
initi
appear
inconsist
evid
virus
switch
receptor
specif
appar
eas
dramat
suggest
shift
influenza
virus
anim
reservoir
involv
singl
amino
acid
chang
viral
hemagglutinin
enabl
recognit
differ
sialic
acid
structur
eg
nacetyl
nglycolyl
neuramin
acid
linkag
galactos
predomin
differ
host
speci
baranowski
et
al
gambaryan
et
al
skehel
wiley
similarli
slight
chang
specif
receptor
accompani
emerg
canin
parvoviru
parker
et
al
howev
small
shift
receptor
specif
rather
global
jump
dissimilar
receptor
similar
slight
shift
involv
chang
coreceptor
usag
aid
progress
scarlatti
et
al
small
shift
usag
highli
similar
receptor
also
report
cell
cultur
select
subgroup
b
e
avian
leukosi
virus
use
polymorph
variant
tvb
receptor
taplitz
coffin
cell
cultur
select
variant
platt
et
al
therefor
despit
rariti
receptor
repertoir
expans
throughout
million
year
retroviru
evolut
limit
switch
occur
within
singl
infect
anim
exampl
evolut
coreceptor
usag
vivo
adapt
ecotrop
mulv
format
polytrop
mulv
evolut
alter
receptor
usag
domest
cat
infect
felva
tailor
et
al
sever
virus
report
use
multipl
altern
receptor
even
altern
pathway
infect
cell
exampl
mv
isol
appear
capabl
use
slam
contain
singl
tm
domain
baranowski
et
al
oldston
et
al
tatsuo
et
al
complex
virus
herpesvirus
contain
sever
distinct
envgp
also
typic
abl
bind
sever
cell
surfac
compon
baranowski
et
al
borza
huttfletch
footandmouth
diseas
picornaviru
fmdv
may
also
use
multipl
receptor
includ
heparan
sulfat
integrin
may
addit
abl
invad
cell
via
immunoglobulin
fc
receptor
viru
coat
antibodi
baranowski
et
al
mason
et
al
altern
entri
rout
also
use
dengu
flaviviru
may
explain
extrem
strong
pathogenesi
occur
reinfect
previous
expos
individu
baranowski
et
al
case
fmdv
establish
whether
heparin
sulfat
true
receptor
directli
mediat
infect
mere
bind
factor
influenc
infect
indirectli
enhanc
viru
adsorpt
infect
also
strongli
stimul
accessori
cell
surfac
bind
compon
includ
heparan
sulfat
glycolipid
dcsign
bounou
et
al
geijtenbeek
et
al
pohlmann
et
al
similarli
paralysisinduc
neurotrop
variant
friend
mulv
bind
strongli
parent
viru
heparan
sulfat
therebi
becom
infecti
brain
capillari
endotheli
cell
still
remain
depend
receptor
jinnoou
et
al
exampl
illustr
chang
affin
accessori
bind
substanc
dramat
alter
cellular
tropism
pathogenesi
virus
often
difficult
distinguish
accessori
bind
factor
true
receptor
coreceptor
essenti
infect
basi
consider
believ
avail
evid
strongli
support
propos
viru
group
sever
constrain
type
receptor
employ
infect
cell
howev
virus
evolv
sever
pathway
infect
virus
evolv
distinct
site
singl
su
glycoprotein
recognit
dissimilar
receptor
coreceptor
complex
envgp
variabl
exampl
simpl
fusion
protein
fast
protein
orthoreoviru
belong
howev
famili
envelop
viru
barri
et
al
shmulevitz
duncan
orthoreoviru
genu
includ
noenvelop
virus
caus
cellcel
fusion
infect
cell
fusion
activ
due
small
nostructur
membran
viral
protein
name
fast
protein
fusionassoci
small
transmembran
protein
size
rang
kda
fast
protein
ectodomain
small
extrem
case
residu
contain
hydrophob
short
region
withwithout
acid
properti
myristoyl
site
though
small
size
challeng
abil
form
hairpin
structur
fast
protein
express
alon
suffici
induc
membran
fusion
barri
et
al
shmulevitz
duncan
surprisingli
abl
traffic
far
plasma
membran
without
induc
intracellular
disord
inde
opposit
express
retrovir
tm
orthomyxoviru
alon
lead
cell
surfac
membran
express
subunit
block
intracellularli
fusion
induc
fast
protein
broad
question
use
particular
protein
receptor
thu
fusion
protein
simpl
possess
sole
fusion
function
other
compris
sever
domain
addit
domain
involv
fusion
function
domain
remain
less
independ
fusion
domain
sometim
natur
separ
differ
protein
ie
h
f
paramyxovirus
experiment
differ
fragment
explain
case
retrovirus
function
bind
receptor
separ
function
fusion
line
inquiri
initi
studi
bae
et
al
relat
conserv
phq
motif
occur
near
aminotermin
end
su
glycoprotein
retrovirus
mutat
phq
motif
block
membran
fusion
effect
receptor
attach
subsequ
discov
noninfecti
retrovirion
lack
histidin
could
transactiv
addit
solubl
su
aminotermin
fragment
su
call
receptorbind
domain
rbd
cultur
cell
lavillett
et
al
interestingli
studi
overbaugh
cowork
demonstr
similar
transactiv
process
occur
natur
infect
retrovirus
specif
found
infect
immunosuppress
felvt
viru
pro
place
phq
motif
requir
transactiv
either
solubl
felvbrel
su
glycoprotein
term
felix
endogen
express
cat
cell
felvb
su
glycoprotein
activ
process
parallel
herp
simplex
viru
transmiss
fusogen
signal
among
envgp
herp
simplex
viru
receptor
bind
glycoprotein
gd
solubl
gd
ectodomain
shown
allow
entri
engin
viru
particl
lack
gd
ie
gdnull
mutant
cocchi
et
al
evid
review
provid
strong
support
hypothesi
attach
virus
receptor
initi
pathway
obligatorili
contain
intermedi
step
intermedi
step
like
includ
viral
associ
multipl
receptor
cooper
conform
chang
within
env
glycoprotein
crosstalk
env
viral
surfac
case
retrovirus
evid
suggest
viru
bind
receptor
directli
induc
irrevers
structur
chang
sutm
complex
previous
believ
rather
impli
bind
receptor
induc
susu
interact
prerequisit
later
step
highli
coordin
membran
fusion
pathway
anticip
similar
intermedi
step
like
involv
infect
group
retrovirus
perhap
infect
membraneenvelop
virus
virus
activ
solubl
receptor
interact
envelop
glycoprotein
induc
conform
chang
necessari
trigger
fusion
exampl
indic
bind
fusion
step
separ
take
place
differ
locat
case
mhv
avian
retroviru
aslv
herp
simplex
infect
cell
harbor
bind
receptor
provid
solubl
form
present
infect
media
solubl
receptor
mhvr
solubl
tva
receptor
aslv
solubl
kwon
et
al
matsuyama
taguchi
moth
et
al
vector
deriv
retrovirus
lentivirus
oncoretrovirus
probabl
among
suitabl
tool
achiev
longterm
gene
transfer
sinc
allow
stabl
integr
transgen
propag
daughter
cell
lentivir
vector
prefer
genedeliveri
vehicl
vector
deriv
oncoretrovirus
mlv
sinc
contrast
latter
transduc
nonprolifer
target
cell
moreov
lentivir
vector
capac
deliv
transgen
specif
tissu
expect
great
valu
variou
gene
transfer
approach
vivo
frecha
et
al
achiev
vivo
gene
transfer
innov
approach
develop
upgrad
lentivir
vector
tissu
cell
target
potenti
vivo
gene
deliveri
one
strategi
develop
vector
harbor
envgp
select
tropism
vector
deriv
retrovirus
offer
particularli
flexibl
properti
gene
transfer
applic
given
numer
possibl
associ
variou
viral
surfac
glycoprotein
determin
cell
tropism
viral
core
select
tropism
achiev
take
advantag
natur
tropism
envgp
membraneenvelop
virus
instanc
use
surfac
glycoprotein
deriv
virus
caus
lung
infect
infect
via
airway
epithelia
ebola
viru
influenza
viru
may
prove
use
gene
therapi
human
airway
kobing
et
al
exclus
transduct
retin
pigment
epithelium
could
achiev
follow
subretin
inocul
vector
pseudotyp
rat
eye
duisit
et
al
high
transgen
express
detect
dermal
fibroblast
transduc
vsvg
eboz
mulvpseudotyp
hiv
vector
effect
target
quiescent
epiderm
stem
cell
underw
termin
differenti
result
transgen
express
progeni
hachiya
et
al
importantli
sever
viral
envgp
target
lentivir
vector
cn
rabi
wong
et
al
mokola
watson
et
al
wong
et
al
lymphocyt
choriomening
viru
envelop
lcmv
milet
et
al
stein
et
al
ross
river
kang
et
al
viral
envgp
even
permit
transduct
specif
cell
type
within
cn
likewis
screen
larg
panel
pseudotyp
vector
establish
superior
gibbon
ape
leukemia
viru
galv
stitz
et
al
cat
endogen
retroviralmodifi
glycoprotein
transduct
progenitor
differenti
hematopoiet
cell
recent
new
lv
carri
mv
envgp
surfac
abl
overcom
vector
restrict
quiescent
b
cell
frecha
et
al
frecha
et
al
importantli
naiv
well
memori
b
cell
effici
transduc
appar
activ
cellcycl
entri
phenotyp
switch
detect
open
door
multitud
gene
therapi
immunotherapi
applic
vector
deriv
hiv
pseudotyp
sendai
viru
fusion
protein
f
kowolik
yee
hepat
c
viru
bartosch
et
al
vector
abl
transduc
human
hepatoma
cell
primari
human
hepatocyt
effici
although
unabl
enter
nonliv
cell
glycoprotein
baculoviru
autographa
californica
multinuclear
polyhedrosi
viru
pseudotyp
fiv
effici
also
show
excel
hepatocyt
tropism
kang
et
al
screen
cdna
librari
emerg
power
tool
identifi
clone
viral
entri
receptor
altern
use
humanchines
hamster
radiat
hybrid
panel
cell
order
clone
unknown
receptor
complement
screen
cdna
cell
permiss
infect
certain
viru
introduc
nonpermiss
cell
recess
cell
line
poorli
transfect
use
pseudoparticl
provid
good
tool
transduc
cdna
librari
clone
strategi
retrovir
cdna
librari
approach
involv
transfer
express
cdna
highli
infect
cell
nonpermiss
cell
use
clone
identifi
mulv
polytrop
xreceptor
tailor
et
al
yang
et
al
receptor
tailor
et
al
felvc
receptor
human
domest
cat
cdna
librari
quigley
et
al
tailor
et
al
two
close
relat
human
protein
function
receptor
perva
ericsson
et
al
briefli
cell
line
suscept
particular
pseudotyp
retroviru
vector
harbor
envelop
receptor
known
cdna
librari
cell
line
highli
suscept
transduct
construct
clone
cdna
retrovir
express
vector
afterward
cdna
retrovir
express
librari
transduc
nonsuscept
cell
infect
rel
low
multipl
infect
major
infect
would
contain
singlecopi
proviru
insert
librarycontain
cell
screen
suscept
pseudotyp
vector
transduct
select
drugresist
cell
exposur
vector
carri
resist
gene
drugresist
clone
obtain
primari
screen
use
pcr
primer
specif
vector
sequenc
cdna
product
clone
confer
suscept
identifi
nest
pcr
perform
dna
extract
reinfect
clone
howev
mani
virus
initi
attempt
use
retrovir
cdna
librari
unsuccess
due
inher
background
nonspecif
infect
pseudoparticl
fact
cell
line
complet
nonpermiss
even
envelop
pseudoparticl
bear
viral
envelop
protein
indic
exist
nonspecif
uptak
mechan
screen
result
high
background
drugresist
coloni
independ
glycoproteinmedi
cell
entri
thu
unless
entri
factor
cdna
highli
repres
librari
singl
round
transductionchalleng
would
suffic
deal
high
background
observ
screen
method
would
allow
multipl
round
select
enrich
develop
recent
use
cyclic
packag
rescu
cpr
system
use
nonselfinactiv
vector
shown
increas
effici
receptor
clone
power
iter
screen
method
evan
et
al
retrovir
vector
commonli
use
genedeliveri
applic
selfinactiv
vector
contain
delet
long
termin
repeat
ltr
element
packag
compet
retrovir
rna
transcript
gener
integr
provirus
instead
transgen
express
driven
intern
nonretrovir
promot
contrast
cdna
librari
construct
proviru
retain
complet
ltr
element
retrovir
promot
activ
transduc
cell
fulllength
viral
rna
express
express
packag
compon
gagpol
vesicular
stomat
viru
vsvg
envelop
effici
infect
recess
cell
line
cell
allow
packag
rna
pseudoparticl
capabl
transduc
naiv
cell
approach
term
cpr
bhattacharya
et
al
koh
et
al
allow
retriev
librari
select
perform
follow
transduct
naiv
cell
popul
conclud
new
round
select
process
repeat
sequenti
unlimit
number
select
enrich
step
addit
level
select
differ
challeng
viru
genom
use
encod
differ
drugselect
marker
eg
puromycin
puror
zeocin
zeor
resist
selfinactiv
retrovirus
thu
challeng
select
librarytransduc
popul
one
pseudoparticlepackag
select
cassett
eg
puror
popul
pool
rechalleng
secondselect
pseudoviru
eg
zeor
cpr
fulllength
retrovir
transcript
nonselfinactiv
proviru
encod
librari
selfinactiv
challeng
viru
genom
repackag
transfer
naiv
cell
popul
enabl
research
perform
multipl
round
select
therebi
overcom
background
nonspecif
pseudoparticl
uptak
moreov
use
scheme
underrepres
cdna
enrich
final
round
select
pseudotypesuscept
cell
achiev
genom
dna
prepar
select
clone
use
templat
pcr
across
proviru
cdnaclon
site
nonpermiss
target
cell
line
cdna
screen
adher
sever
stringent
criteria
state
primari
requir
minim
nonspecif
background
cell
line
minim
uptak
pseudoparticl
interest
envelop
pseudoparticl
prefer
ensur
nonpermiss
phenotyp
due
lack
pseudoparticlespecif
entri
factor
rather
poor
infect
pseudotyp
gener
chosen
cell
line
highli
permiss
unrel
pseudoparticl
vsvgpp
rhabdoviru
infect
addit
also
ensur
target
cell
line
would
easili
transduc
cdna
librari
select
candid
cell
line
also
suscept
desir
drug
select
perform
multipl
round
screen
involv
cpr
ideal
cell
line
demonstr
method
well
highli
transfect
final
facilit
screen
chosen
cell
line
need
rel
fast
grow
clone
effici
gain
insight
viru
entri
necessari
examin
sever
inhibitor
pathwaymedi
endocytosi
term
role
block
infect
mediat
pseudotyp
differ
envgp
advantag
pseudoparticl
entri
process
pathogen
studi
condit
exampl
gain
insight
ebola
viru
entri
inhibitor
differ
endocytosi
pathway
examin
abil
block
infect
mediat
hiv
pseudotyp
ebola
envgp
bhattacharyya
et
al
use
control
pseudoparticl
eg
pseudotyp
vesicular
stomat
viru
envgp
vsv
g
use
control
assess
cell
viabil
specif
inhibit
inhibit
clathrin
function
tradit
reli
three
princip
approach
drug
inhibit
acidif
endosom
specif
nonrevers
endosom
proton
pump
inhibitor
well
commonli
use
lysosomotrop
agent
ammonium
chlorid
nh
cl
chloroquin
potassium
deplet
final
treatment
cell
brefeldin
bfa
chlorpromazin
sieczkarski
whittak
drug
multipl
effect
cell
function
use
inhibit
viru
infect
treat
caution
thank
pseudotyp
studi
implic
actin
cytoskeleton
ebola
viru
entri
agent
cytochalasin
swinholid
impair
microfila
function
shown
inhibit
envgpmedi
entri
yonezawa
et
al
ebola
enter
cell
lowphdepend
endocytosismedi
process
larg
bodi
evid
indic
ebola
virus
enter
cell
clathrinmedi
endocytosi
sanchez
lipid
raftassoci
caveolinmedi
endocytosi
also
propos
altern
mechan
ebola
viru
uptak
empig
goldsmith
lowph
event
lead
cathepsindepend
cleavag
ebola
viru
envgp
requir
product
uptak
viru
chandran
et
al
kaletski
et
al
schornberg
et
al
lowphdepend
event
postul
requir
well
schornberg
et
al
furthermor
ebola
viru
like
use
rhomedi
pathway
seen
vsv
viru
suggest
may
rout
entri
util
mani
differ
virus
quinn
et
al
recent
protein
interf
endocytosi
use
dominantneg
rna
interfer
rnai
develop
approach
target
differ
pathway
higher
specif
mercer
heleniu
mercer
et
al
rnai
approach
allow
research
perform
screen
identifi
previous
unrecogn
host
factor
requir
viral
replic
rnai
screen
reli
either
short
interf
rna
sirna
short
hairpin
rna
shrna
knock
function
particular
gene
cell
research
infect
cell
specif
virus
monitor
level
viral
replic
viral
replic
reduc
knockeddown
gene
might
necessari
viru
replic
function
within
host
cell
smallscal
screen
develop
use
wildtyp
virus
kolokoltsov
et
al
pseudoparticl
trotard
et
al
pseudoparticl
exploit
focu
sirna
screen
specif
entri
step
viru
inde
entri
step
govern
envgp
wherea
uncoat
integr
express
step
transgen
depend
retrovir
protein
said
suffer
inher
drawback
step
depend
retrovir
protein
therefor
limit
scope
screen
one
limit
sirna
screen
specif
cell
toxic
overcom
use
pseudotyp
inde
sirna
screen
done
differ
pseudotyp
parallel
contrari
pseudotyp
interest
pseudotyp
affect
sirna
indic
sirna
specif
inhibit
viru
interest
moreov
sirna
toxic
better
character
entri
pathway
hepat
c
viru
small
interf
rna
librari
dedic
membran
traffick
remodel
screen
context
liver
cell
line
cell
infect
hcv
pseudoparticl
hcvpp
trotard
et
al
result
show
downregul
differ
factor
implic
clathrinmedi
endocytosi
inhibit
hcvpp
cell
infect
addit
knockdown
phosphatidylinositol
type
iiialpha
prevent
infect
hcvpp
presenc
host
cell
influenc
suscept
hcvpp
infect
librari
screen
use
pseudoparticl
identifi
two
kinas
beta
involv
hcv
life
cycl
result
confirm
publish
work
identif
cellular
factor
requir
hcv
life
cycl
use
sirna
librari
screen
either
drugabl
gene
ng
et
al
vaillancourt
et
al
cellular
membranetraffick
gene
coller
et
al
kinom
supekova
et
al
entir
genom
li
et
al
tai
et
al
work
much
timeand
costconsum
even
though
pseudoparticl
may
appear
overli
simpl
model
studi
identifi
host
factor
necessari
viral
infect
also
power
flexibl
tool
led
major
discoveri
exampl
shown
recent
howev
order
identifi
host
factor
necessari
viral
infect
research
turn
genomewid
genet
screen
inde
sequenc
human
genom
emerg
technolog
allow
silenc
individu
gene
cell
one
one
use
sirna
combin
use
genomewid
sirna
librari
autom
ht
methodolog
allow
molecular
inform
gain
virtual
everi
critic
intracellular
event
occur
viru
infect
within
last
year
sever
public
describ
genomewid
sirna
screen
appli
viru
infect
tissuecultur
cell
rnai
screen
preform
sever
virus
includ
hiv
konig
et
al
yeung
et
al
zhou
et
al
west
nile
viru
krishnan
et
al
influenza
karla
et
al
konig
et
al
drosophila
cell
dengu
session
et
al
vaccinia
viru
moser
et
al
hundr
cellular
factor
implic
outcom
infect
alreadi
known
studi
major
entir
novel
valid
analysi
data
ongo
mani
laboratori
howev
poor
overlap
result
differ
screen
publish
virus
observ
differ
probabl
link
technic
variat
also
inher
risk
fals
posit
offtarget
effect
fals
neg
due
ineffici
silenc
cell
toxic
common
complic
well
celltyp
specif
followingup
screen
pseudoparticl
studi
use
valid
cell
protein
involv
entri
step
facilit
analysi
compar
use
replic
compet
viru
resist
individu
antivir
like
develop
specif
therapeut
target
particular
viral
protein
thu
make
therapi
consist
combin
drug
target
differ
stage
viral
life
cycl
highli
desir
entri
process
repres
anoth
seri
potenti
target
therapeut
intervent
extens
explor
due
highthroughput
experiment
limit
virus
requir
biosafeti
level
virus
robust
infect
system
pseudoparticl
infect
system
util
differ
report
gene
protein
ie
firefli
luciferas
gfp
develop
ht
small
molecul
librari
peptid
librari
neutral
antibodi
entri
inhibitor
properti
order
facilit
screen
assay
perform
improv
modifi
properti
parent
host
cell
line
pseudoviru
exampl
cell
improv
pseudoparticl
entri
cell
spread
select
pseudoparticl
improv
use
envgp
increas
infect
either
select
specif
variant
express
human
codonoptim
envelop
glycoprotein
sequenc
final
pseudovirus
engin
express
human
codonoptim
report
improv
sensit
assay
use
modif
ht
develop
use
plate
compound
found
inhibit
pseudoparticl
infect
counterscreen
pseudoparticl
contain
variant
character
crossreact
molecul
viru
famili
moreov
molecul
counterscreen
pseudoparticl
harbor
envgp
viru
famili
evalu
specif
inhibitor
larg
spectrum
wide
varieti
entri
inhibitor
name
peptid
chemic
compound
antibodi
exist
interfer
differ
step
entri
process
bind
receptor
conform
chang
fusion
protein
act
envelop
protein
acidif
endosom
necessari
endocytosi
hiv
market
drug
treat
aid
inhibitor
revers
transcriptas
proteas
enzym
new
target
includ
integras
enzym
cellsurfac
interact
membran
fusion
also
viru
particl
matur
assembl
kaushikbasu
et
al
entri
inhibit
entail
prevent
breach
cell
either
strategi
prevent
infect
altogeth
curtail
infect
new
cell
hivposit
individu
sever
strategi
prove
effect
entri
inhibit
either
vitro
use
pseudoparticl
replic
compet
virus
vivo
bind
viral
surfac
protein
bind
human
cell
surfac
receptor
bind
human
cell
surfac
coreceptor
leonard
roy
liu
et
al
particular
synthes
peptid
believ
act
bind
wild
et
al
wild
et
al
current
clinic
use
yet
sever
recent
studi
reveal
block
sixhelix
bundl
prehairpin
format
liu
et
al
anoth
peptid
deriv
cterminu
nearli
ident
wide
report
cpeptid
liu
et
al
root
et
al
also
describ
strong
antihiv
entri
activ
due
tight
bind
ntermin
helic
maraviroc
small
antiretrovir
compound
known
antagonist
block
hiv
entri
cell
hunt
romanelli
sever
studi
establish
synergi
occasion
observ
two
fusion
inhibitor
combin
viral
assay
vitro
fusion
assay
exampl
synergi
observ
combin
antibodi
ji
et
al
murga
et
al
combin
small
molecular
antagonist
coreceptor
tremblay
et
al
combin
small
molecular
antagonist
antibodi
ji
et
al
murga
et
al
combin
small
molecular
antagonist
chemokin
murga
et
al
tremblay
et
al
case
hcv
entri
hepatocyt
multistep
process
involv
least
four
cellular
receptor
lead
virion
endocytosi
fusion
viral
cellular
membran
unlik
hcv
replic
process
step
thoroughli
exploit
target
antivir
intervent
recent
develop
hcvpp
infecti
molecular
clone
becom
possibl
test
drug
entri
vitro
proofofconcept
studi
inhibit
hcv
entri
process
demonstr
use
cyanovirinn
target
nlink
glycan
viral
envelop
protein
prevent
interact
hell
et
al
neutral
antibodi
direct
hcv
protein
broer
et
al
habersetz
et
al
keck
et
al
law
et
al
owsianka
et
al
perotti
et
al
schofield
et
al
yu
et
al
antibodi
cellular
receptor
bartosch
et
al
cormier
et
al
lavillett
et
al
molina
et
al
srbi
catanes
et
al
zeisel
et
al
krieger
et
al
agent
block
endosom
acidif
bartosch
et
al
hsu
et
al
koutsoudaki
et
al
lavillett
et
al
vivo
studi
use
human
trimera
mice
model
human
liverupascid
mice
also
demonstr
prophylact
efficaci
monoclon
eren
et
al
antibodi
meuleman
et
al
respect
broadspectrum
antivir
drug
also
test
pecheur
et
al
recent
studi
use
hcvpp
system
order
undertak
screen
campaign
led
discoveri
class
small
molecul
hcvspecif
inhibitor
consist
sever
structur
relat
compound
defin
common
triazin
core
baldick
et
al
inhibit
entri
confirm
use
timeofaddit
experi
demonstr
inhibitor
activ
confin
first
h
infect
inhibit
occur
postattach
close
link
inhibit
kinet
endosom
acidif
inhibitor
bafilomycin
pseudoparticl
also
use
identifi
mode
action
molecul
identifi
use
replic
compet
viru
cellbas
screen
system
involv
multipl
round
infect
format
analysi
publicli
avail
librari
clinic
approv
drug
impact
identifi
compound
viral
entri
test
use
hcvpp
infect
recapitul
hcv
particl
adsorpt
intern
viral
envelopemedi
fusion
gastaminza
et
al
mani
candid
lysosomotrop
compound
inhibit
hcv
entri
differenti
efficaci
pseudotyp
larson
et
al
infecti
viru
screen
bolken
et
al
identifi
broadli
activ
arenaviru
entri
inhibitor
isol
map
resist
virus
well
chimera
sensit
resist
strain
map
target
activ
subunit
g
envelop
protein
complex
specif
interfac
ctermin
stem
tmd
domain
mechanist
studi
show
arenaviru
inhibitor
prevent
lowphinduc
fusion
block
reorgan
stem
ntermin
domain
g
protein
complex
york
et
al
anoth
altern
develop
entri
inhibitor
compound
target
endosom
proteas
necessari
entri
certain
virus
inhibitor
cathepsin
l
block
viral
entri
sever
acut
respiratori
syndrom
coronaviru
sarscov
ebola
viru
impair
convers
hev
glycoprotein
matur
activ
form
chandran
et
al
pager
dutch
simmon
et
al
respect
develop
antivir
agent
inhibitor
human
cathepsin
l
subject
resist
aris
rapid
mutat
viral
genom
shah
et
al
make
cathepsin
l
attract
target
drug
develop
ht
cathepsin
l
inhibitor
identifi
novel
thiocarbaz
compound
exhibit
potent
inhibit
cathepsin
l
myer
et
al
shah
et
al
compound
prevent
cell
infect
ebola
sarscov
pseudotyp
respect
addit
thiocarbaz
inhibit
vitro
propag
malaria
parasit
plasmodium
falciparum
inhibit
leishmania
major
final
anoth
natur
entri
inhibitor
provid
monoclon
neutral
antibodi
mani
monoclon
antibodi
isol
immort
bcell
recov
patient
mice
hybridoma
follow
immun
antibodi
select
elisa
assay
use
solubl
envelop
protein
pseudoparticl
neutral
potenti
antibodi
easili
screen
use
pseudoparticl
highthroughput
infect
assay
inhibitori
effect
verifi
replic
virus
case
hcv
use
antibodi
antigenbind
fragment
phagedisplay
librari
gener
donor
chronic
infect
hcv
clone
show
specif
bind
hcv
glycoprotein
monoclon
antibodi
present
neutral
activ
cellcultur
hcv
hcvcc
viru
panel
hcvpp
display
divers
genotyp
law
et
al
overal
neutral
antibodi
inhibit
differ
step
entri
process
bind
membran
fusion
target
domain
involv
step
limit
conform
chang
envelop
complex
interestingli
one
studi
recent
highlight
feasibl
target
shortliv
envelop
glycoprotein
intermedi
inhibit
membran
fusion
use
monoclon
antibodi
york
et
al
action
similar
peptid
hiv
membran
fusion
market
strategi
effect
target
fusion
peptid
function
endosom
may
lead
discoveri
novel
class
antivir
agent
screen
use
pseudoparticl
provid
easili
wield
system
identifi
infrequ
antibodi
virus
develop
vari
mechan
reach
goal
vari
greatli
structur
seem
common
mechan
action
ligandtrigg
largescal
conform
chang
fusion
protein
coupl
apposit
merger
two
bilay
spite
differ
mechan
activ
fusion
peptid
fusion
protein
distribut
three
class
base
structur
homolog
futur
experi
must
aim
elucid
molecular
mechan
dynam
conform
chang
drive
viru
entri
requir
develop
new
approach
studi
rapid
conform
chang
small
number
membran
interact
protein
molecul
domain
realist
goal
determin
structur
protein
mediat
entri
human
virus
either
prebind
postfus
stage
anoth
challeng
identif
cognat
cellular
receptor
identif
cellular
receptor
human
virus
would
import
contribut
understand
viru
tropism
pathogenesi
known
role
receptor
entri
specif
nonspecif
bind
factor
receptor
need
conform
chang
rout
viru
right
compart
establish
moreov
virus
envgp
appear
function
autonom
manner
permit
fusion
without
requir
receptor
acid
ph
thu
role
vari
receptor
remain
enigmat
mani
virus
difficult
predict
role
receptor
fusion
sort
rout
viru
toward
particular
favor
compart
pursuit
infecti
cycl
base
upon
famili
structur
activ
process
envgp
postbind
event
earli
step
crucial
understand
could
provid
target
develop
therapeut
better
understand
envelopereceptor
interact
also
rais
hope
possibl
design
entri
machin
deliv
gene
molecul
cell
choic
recent
use
whole
genom
sirna
screen
becom
wide
use
differ
virus
order
identifi
factor
import
entri
drastic
increas
knowledg
factor
necessari
entri
virus
similarli
mani
highthroughput
interactom
studi
identifi
cellular
protein
interact
differ
viral
compon
altogeth
comparison
highthroughput
screen
help
us
identifi
cellular
protein
pathway
common
differ
virus
may
help
ration
structuremechanismbas
design
entri
inhibitor
develop
inhibitor
crossreact
differ
pathogen
similar
fashion
design
vaccin
immunogen
capabl
elicit
potent
broadli
neutral
antibodi
known
epitop
expect
contribut
toward
develop
vaccin
parallel
develop
panel
human
monoclon
antibodi
everi
entryrel
protein
pathogen
human
virus
could
acceler
understand
entri
mechan
help
fight
viral
diseas
research
continu
present
pace
goal
could
accomplish
within
next
decad
